BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20541523)

  • 1. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
    Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides: from molecular mechanisms to therapeutics.
    Morris MC; Deshayes S; Heitz F; Divita G
    Biol Cell; 2008 Apr; 100(4):201-17. PubMed ID: 18341479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-based nanoparticle for ex vivo and in vivo drug delivery.
    Crombez L; Morris MC; Deshayes S; Heitz F; Divita G
    Curr Pharm Des; 2008; 14(34):3656-65. PubMed ID: 19075741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
    Kurzawa L; Pellerano M; Morris MC
    Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Happy birthday cell penetrating peptides: already 20 years.
    Brasseur R; Divita G
    Biochim Biophys Acta; 2010 Dec; 1798(12):2177-81. PubMed ID: 20826125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Mechanisms of Peptide-Mediated Delivery of Nucleic Acids Using Electron Microscopy.
    Margus H; Juks C; Pooga M
    Methods Mol Biol; 2015; 1324():149-62. PubMed ID: 26202268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
    Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
    PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask).
    Konate K; Rydstrom A; Divita G; Deshayes S
    Curr Pharm Des; 2013; 19(16):2869-77. PubMed ID: 23140452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
    Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
    Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.